Ophthalmology Times Europe Newsletter

To view this email as a web page, click here.

Nerve growth factor promising for dry eye

Recombinant human nerve growth factor (rhNGF) has shown promise as a treatment for dry eye disease in a phase I clinical trial.

Considering BID ocular steroid post-cataract surgery

In ocular surgery, with penetrating incisions, we inevitably still face postoperative inflammation and pain. Now, a novel potent corticosteroid formulation could help improve that aspect of cataract surgery as well, with enhanced penetration and an easier-to-follow dosing regimen.

Children with behavioural problems run a risk from laser pointers

Children with behavioural problems may hurt themselves with laser pointers, and eye-care professionals should be alert to the risk, researchers say.

The future: Artificial intelligence gains acceptance in ophthalmology

Rho kinase inhibitors getting to the heart of the matter

Managing unique challenges of pediatric congenital cataract

This woman had *what* living in her eye?!

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.